KR880001301A - 지속성 약품 제제 - Google Patents

지속성 약품 제제 Download PDF

Info

Publication number
KR880001301A
KR880001301A KR1019870007706A KR870007706A KR880001301A KR 880001301 A KR880001301 A KR 880001301A KR 1019870007706 A KR1019870007706 A KR 1019870007706A KR 870007706 A KR870007706 A KR 870007706A KR 880001301 A KR880001301 A KR 880001301A
Authority
KR
South Korea
Prior art keywords
oil
group
long
alcohol
acting pharmaceutical
Prior art date
Application number
KR1019870007706A
Other languages
English (en)
Other versions
KR960004857B1 (ko
Inventor
히메노부 안드오
스미오 와다나베
야스오 미야께
Original Assignee
나이또오 유우지
에이자이 가부시기 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 나이또오 유우지, 에이자이 가부시기 가이샤 filed Critical 나이또오 유우지
Publication of KR880001301A publication Critical patent/KR880001301A/ko
Application granted granted Critical
Publication of KR960004857B1 publication Critical patent/KR960004857B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods

Abstract

내용 없음

Description

지속성 약품 제제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제1,2도는 본 발명에 의한 약품 제제로부터 약품의 용해 속도를, 대응하는 대조물로부터 동일한 약품의 용해속도와 비교하여 도표로서 각각 나타낸 것임.

Claims (5)

  1. 필수 성분으로서 수용성 약품, 지질 물질 및 오일로되는 지속성 약품 제제.
  2. 제1항에 있어서, 수용성 약품이 부나조신 염산염, 페닐프로판올아민, 클로르페닐아민 말레산염 및 테오필린으로 되는 군 중에서 선택된 약품 중의 적어도 하나인 것을 특징으로 하는 지속성 약품 제제.
  3. 제1항에 있어서, 지질 물질이 지방족 고급 지방산(예, 스테아르산, 미리스트산 및 팔미트산), 지방족 고급 알코올(예, 라우릴 알코올, 미리스틸 알코올 및 스테아릴 알코올), 고급 지방산의 에스테르(예, 글리세린과 수소첨가 피마자유의 모노스테아레이트, 디스테아레이트 및 트리스레아테이트), 왁스(예, 밀랍, 카르나우바 왁스, 일본 왁스 및 경랍), 및 탄화수소(예, 파라핀), 미세결정성 왁스 및 세레신, 및 지상산의 슈크로오스 에스테르로 되는 군 중에서 선택된 물질 중의 적어도 하나인 것을 특징으로 하는 지속성 약품 제제.
  4. 제1항에 있어서, 오일이 대두유, 면실유, 참깨유, 땅콩유, 올리브유, 해바라기유, 옥틸도데실 글리세리드, 미그리올, 글리세린, 모노카프릴레이트, 실리콘 오일로 되는 군 중에서 선택된 오일중의 적어도 하나인 것을 특징으로 하는 지속성 약품 제제.
  5. 제1항에 있어서, 제제가 정제 또는 과립제의 형태인 것을 특징으로 하는 지속성 약품 제제.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870007706A 1986-07-18 1987-07-16 지속성 약제 KR960004857B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP61-167,865 1986-07-18
JP61167865A JPH0816066B2 (ja) 1986-07-18 1986-07-18 持続性薬効製剤
JP167865 1986-07-18

Publications (2)

Publication Number Publication Date
KR880001301A true KR880001301A (ko) 1988-04-22
KR960004857B1 KR960004857B1 (ko) 1996-04-16

Family

ID=15857516

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870007706A KR960004857B1 (ko) 1986-07-18 1987-07-16 지속성 약제

Country Status (13)

Country Link
US (1) US5030455A (ko)
EP (1) EP0254978B1 (ko)
JP (1) JPH0816066B2 (ko)
KR (1) KR960004857B1 (ko)
AT (1) ATE71291T1 (ko)
CA (1) CA1309656C (ko)
DE (1) DE3775850D1 (ko)
DK (1) DK174931B1 (ko)
ES (1) ES2040228T3 (ko)
FI (1) FI96095C (ko)
GR (1) GR3003536T3 (ko)
NO (1) NO179163C (ko)
PH (1) PH25286A (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
US4975312A (en) * 1988-06-20 1990-12-04 Foster-Miller, Inc. Multiaxially oriented thermotropic polymer substrate for printed wire board
JP2681373B2 (ja) * 1988-07-18 1997-11-26 塩野義製薬株式会社 徐放性製剤の製造法
JP2794022B2 (ja) * 1988-11-11 1998-09-03 三生製薬株式会社 ブナゾシン或いはその塩類含有経皮適用製剤
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
GB2263910A (en) * 1992-02-05 1993-08-11 Co Ordinated Drug Dev Direct compression tablet excipient
IL119660A (en) 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
CN1103586C (zh) * 1993-12-13 2003-03-26 里达克药品公司 蔗糖酯－c20－28醇制剂
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
JPH08143450A (ja) * 1994-11-14 1996-06-04 Taiyo Yakuhin Kogyo Kk 徐放化製剤
CA2233016C (en) * 1995-09-25 2007-07-17 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
US6417326B1 (en) 1996-04-11 2002-07-09 The University Of British Columbia Fusogenic liposomes
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
DE10041479A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923
DE10041478A1 (de) * 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
AU2002351008B2 (en) * 2001-11-30 2007-07-12 Pfizer Products Inc. Pharmaceutical compositions of 5,8,14-triazatetracyclo[10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
US20040096498A1 (en) * 2002-04-29 2004-05-20 Alvin Kershman Oral pharmaceutical delivery system with improved sustained release
EP2650065A4 (en) * 2010-12-08 2014-06-04 Aida Eng Ltd METHOD FOR THE PRODUCTION OF HIGH-DEFINED SINTERING PRESSURE RINGS AND DEVICE FOR THEIR PRODUCTION

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2895881A (en) * 1957-04-04 1959-07-21 Wynn Pharmacal Corp Quinidine gluconate sustained medication tablet
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3655864A (en) * 1970-09-21 1972-04-11 Smith Kline French Lab Glyceryl tristerate and higher fatty acid mixture for improving digestive absorption
US4020159A (en) * 1974-10-08 1977-04-26 Apotheker A. Herbert K.G., Fabrik Pharmazeutischer Praparate Wiesbaden Methods of and medications for treating cardiac disorders by using strophanthin
US4163777A (en) * 1977-04-29 1979-08-07 Lewis/Howe Company Controlled antacid delivery form and method of treatment therewith
US4375468A (en) * 1981-07-13 1983-03-01 Verex Laboratories, Inc. Constant order release aspirin composition and method of treating arthritis
JPS6143108A (ja) * 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
EP0176772B1 (de) * 1984-08-30 1989-03-29 RODISMA Pharmazeutische Produkte GmbH Verfahren zur Retardierung von Vitamin C und E

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030024191A (ko) * 2001-09-17 2003-03-26 주식회사 효성 알칼리 가용성 코폴리에스터 및 이의 제조방법

Also Published As

Publication number Publication date
NO179163C (no) 1996-08-21
DK373187D0 (da) 1987-07-17
CA1309656C (en) 1992-11-03
EP0254978A1 (en) 1988-02-03
DK174931B1 (da) 2004-03-01
PH25286A (en) 1991-04-30
KR960004857B1 (ko) 1996-04-16
DK373187A (da) 1988-01-19
EP0254978B1 (en) 1992-01-08
FI873106A (fi) 1988-01-19
FI96095B (fi) 1996-01-31
NO179163B (no) 1996-05-13
NO872991L (no) 1988-01-19
DE3775850D1 (de) 1992-02-20
FI96095C (fi) 1996-05-10
ES2040228T3 (es) 1993-10-16
GR3003536T3 (ko) 1993-03-16
JPH0816066B2 (ja) 1996-02-21
JPS6327439A (ja) 1988-02-05
US5030455A (en) 1991-07-09
FI873106A0 (fi) 1987-07-14
ATE71291T1 (de) 1992-01-15
NO872991D0 (no) 1987-07-17

Similar Documents

Publication Publication Date Title
KR880001301A (ko) 지속성 약품 제제
HUP0400566A2 (hu) Mátrixon diszpergált hatóanyagot tartalmazó gyógyászati készítmény
KR0167696B1 (ko) 사이클로스포린-함유 연질캅셀제 조성물
US5741766A (en) Oil-in-water cleansing emulsion having the appearance of milk
AU737565B2 (en) Water containing wax-based product
RO111021B1 (ro) Compozitie farmaceutica stabila, cu ciclosporina
CN100581527C (zh) 含有聚甘油中链脂肪酸酯的组合物
US4337241A (en) Emulsions of the water-in-oil or oil-in-water type and cosmetic products using these emulsions
EP1109532A1 (en) Oral micro-emulsion composition of silybin
GB1450308A (en) Pharmaceutical compositions
KR900007397A (ko) 서방성 제제
CN101019833A (zh) 一种用作药物载体的药用油包油型非水微乳及其药物制剂
BR0115986A (pt) Comprimido de desintegração rápida contendo um ingrediente ativo instável aos ácidos
KR900012612A (ko) 제약 조성물
JPH0215248B2 (ko)
JPH0368505A (ja) 油性化粧料
HUP9903855A2 (hu) Orális adagolásra való valproesavat tartalmazó gyógyszerészeti mikrogömbök
JP2006298866A5 (ko)
JPS59130206A (ja) 化粧料の製造方法
JP3131282B2 (ja) 消炎鎮痛外用剤
JP4418550B2 (ja) 疎水性甘草エキス含有組成物
CN1771949B (zh) 尼莫地平软胶囊及其制备方法
JPH07549B2 (ja) 軟カプセル充填用組成物
US5482973A (en) Suppository preparation
JP2718087B2 (ja) 持効化坐剤

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20100413

Year of fee payment: 15

EXPY Expiration of term